Bedside screening of carbapenem-resistant Enterobacteriaceae using selective agar plates: A low-cost, laboratory-independent approach for rural healthcare facilities
4 affiliations
- 1Department of Infectious Diseases, Viet Tiep Hospital, Hai Phong, Viet Nam
- 2HUTECH University, Ho Chi Minh city, Vietnam
- 3Hanoi University of Public Health, Vietnam
- 4University of Medicine and Pharmacy, Ho Chi Minh city, Vietnam
Abstract
The global surge of carbapenem-resistant Enterobacteriaceae (CRE) poses a critical threat to patient safety in intensive care units (ICUs). In low- and middle-income countries, routine CRE surveillance is often limited by the lack of microbiology laboratory infrastructure and trained personnel in peripheral healthcare facilities, resulting in reliance on empirical broad-spectrum antibiotic therapy and limited capacity to detect silent transmission. This study evaluated the operational feasibility, safety, and phenotypic agreement of a decentralized, laboratory-independent bedside CRE screening protocol using pre-formulated selective chromogenic agar and a low-cost portable incubator. Dual rectal swabs were collected from 220 ICU patients at Viet Tiep Hospital, Vietnam. One sample was processed using standard centralized laboratory procedures as the reference method, while the parallel sample was processed at the bedside by frontline nursing staff, including direct plate inoculation and point-of-care incubation. Diagnostic agreement, inter-reader reliability, procedural contamination, and operational feasibility were assessed. Gastrointestinal CRE carriage was identified in 26 of 220 patients (11.8%), with the KESC group accounting for 76.9% of positive cases. The bedside protocol demonstrated 100% phenotypic concordance with standard laboratory cultures, with 100% sensitivity, specificity, positive predictive value, and negative predictive value. Blinded assessment showed complete inter-reader agreement (κ = 1.0). No environmental cross-contamination was detected on CRE-negative plates (0.0%; 95% CI: 0–4.1%). The decentralized bedside screening model, costing less than US$1 per test, demonstrated high diagnostic agreement and operational feasibility when performed by frontline nursing staff in a non-sterile ICU environment. This approach may provide an affordable alternative for CRE surveillance in resource-limited healthcare facilities where centralized microbiology laboratory infrastructure is unavailable.
Related
- Occurrence and molecular characteristics of carbapenem-resistant Enterobacteriaceae recovered from wildlife: a systematic review and meta-analysis
- Modeling the impact of healthcare personnel compensation and benefits on the spread of COVID-19 in skilled nursing facilities
- Multidrug resistance in bacteria causing community-acquired urinary tract infections among adult outpatients attending primary healthcare facilities in Mwanza, Tanzania
- Genomic epidemiology of blaCTX−M−65-positive clinical Enterobacteriaceae reveals clonal diversity and shared plasmid backbones
- Phylogenetic Analysis of cpn60 UT region reveal oligonucleotide regions for the detection of prominent Enterobacteriaceae pathogens
BibTeX
@article{ngo2026bedside,
title = {{Bedside screening of carbapenem-resistant Enterobacteriaceae using selective agar plates: A low-cost, laboratory-independent approach for rural healthcare facilities}},
author = {The Anh Ngo and Hieu Thi Nguyen and Nhung Ngoc Hoang and Thanh Duc Nguyen and Thanh Chi Tran},
journal = {PLOS Global Public Health},
year = {2026},
month = oct,
doi = {10.1371/journal.pgph.0007479},
url = {https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0007479},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Bedside screening of carbapenem-resistant Enterobacteriaceae using selective agar plates: A low-cost, laboratory-independent approach for rural healthcare facilities
AU - The Anh Ngo
AU - Hieu Thi Nguyen
AU - Nhung Ngoc Hoang
AU - Thanh Duc Nguyen
AU - Thanh Chi Tran
PY - 2026
DA - 2026/10/15
JO - PLOS Global Public Health
DO - 10.1371/journal.pgph.0007479
UR - https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0007479
AB - The global surge of carbapenem-resistant Enterobacteriaceae (CRE) poses a critical threat to patient safety in intensive care units (ICUs). In low- and middle-income countries, routine CRE surveillance is often limited by the lack of microbiology laboratory infrastructure and trained personnel in peripheral healthcare facilities, resulting in reliance on empirical broad-spectrum antibiotic therapy and limited capacity to detect silent transmission. This study evaluated the operational feasibility, safety, and phenotypic agreement of a decentralized, laboratory-independent bedside CRE screening protocol using pre-formulated selective chromogenic agar and a low-cost portable incubator. Dual rectal swabs were collected from 220 ICU patients at Viet Tiep Hospital, Vietnam. One sample was processed using standard centralized laboratory procedures as the reference method, while the parallel sample was processed at the bedside by frontline nursing staff, including direct plate inoculation and point-of-care incubation. Diagnostic agreement, inter-reader reliability, procedural contamination, and operational feasibility were assessed. Gastrointestinal CRE carriage was identified in 26 of 220 patients (11.8%), with the KESC group accounting for 76.9% of positive cases. The bedside protocol demonstrated 100% phenotypic concordance with standard laboratory cultures, with 100% sensitivity, specificity, positive predictive value, and negative predictive value. Blinded assessment showed complete inter-reader agreement (κ = 1.0). No environmental cross-contamination was detected on CRE-negative plates (0.0%; 95% CI: 0–4.1%). The decentralized bedside screening model, costing less than US$1 per test, demonstrated high diagnostic agreement and operational feasibility when performed by frontline nursing staff in a non-sterile ICU environment. This approach may provide an affordable alternative for CRE surveillance in resource-limited healthcare facilities where centralized microbiology laboratory infrastructure is unavailable.
SN - 2767-3375
ER -